Epidemiological trends of synovial sarcoma by primary tumor sites in the US from 2000 to 2020

IF 2.4 3区 医学 Q3 ONCOLOGY Cancer Epidemiology Pub Date : 2024-07-23 DOI:10.1016/j.canep.2024.102627
Riddhi R. Patel , George L. Delclos , Stacia M. DeSantis , Michael B. Cannell , Philip J. Lupo , Patrick P. Lin , Dejka M. Araujo
{"title":"Epidemiological trends of synovial sarcoma by primary tumor sites in the US from 2000 to 2020","authors":"Riddhi R. Patel ,&nbsp;George L. Delclos ,&nbsp;Stacia M. DeSantis ,&nbsp;Michael B. Cannell ,&nbsp;Philip J. Lupo ,&nbsp;Patrick P. Lin ,&nbsp;Dejka M. Araujo","doi":"10.1016/j.canep.2024.102627","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Synovial sarcoma (SS) is a rare soft-tissue cancer. Existing literature encompasses Surveillance, Epidemiology, and End Results (SEER) data-based research on SS explaining the incidence-prevalence in general, by subtypes, and by age at diagnosis. Therefore, this study aimed to fill in the gap of knowledge about measures of disease occurrence and burden of SS by tumor site using the SEER database.</p></div><div><h3>Methods</h3><p>In this cross-sectional study, primary SS patients were selected from SEER 17 Registries, Nov. 2021 (2000–2020) using ICD-O-3 codes 9040, 9041, 9042, and 9043. Patients with additional cancers were excluded. The primary tumor site was categorized into (1) head/neck, (2) internal thorax, (3) abdomen/pelvis, (4) upper extremity, and (5) lower extremity using ICD-10CM codes. Five outcomes were analyzed: age-adjusted incidence rate, 5-year limited-duration prevalence rate, incidence-based mortality, case-fatality rate, and overall survival.</p></div><div><h3>Results</h3><p>From 2000–2020, the overall age-adjusted incidence rate was 0.15 per 100,000; the 5-year limited duration prevalence rate was 0.56 per 100,000; and the incidence-based mortality rate was 0.06 per 100,000 people. The case-fatality and 5-year OS rates were 39.2 % and 62.9 %, respectively. Lower extremity had the highest incidence of 0.07 (estimated 1166 cases), prevalence of 0.36 (estimated 224 cases), and mortality rate of 0.025 (estimated 429 deaths) per 100,000. The other four locations had much closer rates with each other. Intrathoracic SS had the highest case-fatality rate of 71.5 % (148/207) and lowest 5-year OS of 26.0 % (95 % CI: 19.6 %, 32.9 %) than other sites.</p></div><div><h3>Conclusion</h3><p>Based on the measures of disease frequency, the most common primary tumor site is the lower extremity, followed by the upper extremity, abdomen/pelvis, internal thorax, and head/neck. The least favorable primary location is the internal thorax. Those with a primary location of the upper extremity have the longest overall survival, followed by the head/neck, lower extremity, abdomen/pelvis, and internal thorax.</p></div>","PeriodicalId":56322,"journal":{"name":"Cancer Epidemiology","volume":"92 ","pages":"Article 102627"},"PeriodicalIF":2.4000,"publicationDate":"2024-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1877782124001061/pdfft?md5=b7cffb19bd985669a4e57b17891ba1c2&pid=1-s2.0-S1877782124001061-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Epidemiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1877782124001061","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Synovial sarcoma (SS) is a rare soft-tissue cancer. Existing literature encompasses Surveillance, Epidemiology, and End Results (SEER) data-based research on SS explaining the incidence-prevalence in general, by subtypes, and by age at diagnosis. Therefore, this study aimed to fill in the gap of knowledge about measures of disease occurrence and burden of SS by tumor site using the SEER database.

Methods

In this cross-sectional study, primary SS patients were selected from SEER 17 Registries, Nov. 2021 (2000–2020) using ICD-O-3 codes 9040, 9041, 9042, and 9043. Patients with additional cancers were excluded. The primary tumor site was categorized into (1) head/neck, (2) internal thorax, (3) abdomen/pelvis, (4) upper extremity, and (5) lower extremity using ICD-10CM codes. Five outcomes were analyzed: age-adjusted incidence rate, 5-year limited-duration prevalence rate, incidence-based mortality, case-fatality rate, and overall survival.

Results

From 2000–2020, the overall age-adjusted incidence rate was 0.15 per 100,000; the 5-year limited duration prevalence rate was 0.56 per 100,000; and the incidence-based mortality rate was 0.06 per 100,000 people. The case-fatality and 5-year OS rates were 39.2 % and 62.9 %, respectively. Lower extremity had the highest incidence of 0.07 (estimated 1166 cases), prevalence of 0.36 (estimated 224 cases), and mortality rate of 0.025 (estimated 429 deaths) per 100,000. The other four locations had much closer rates with each other. Intrathoracic SS had the highest case-fatality rate of 71.5 % (148/207) and lowest 5-year OS of 26.0 % (95 % CI: 19.6 %, 32.9 %) than other sites.

Conclusion

Based on the measures of disease frequency, the most common primary tumor site is the lower extremity, followed by the upper extremity, abdomen/pelvis, internal thorax, and head/neck. The least favorable primary location is the internal thorax. Those with a primary location of the upper extremity have the longest overall survival, followed by the head/neck, lower extremity, abdomen/pelvis, and internal thorax.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
2000 年至 2020 年美国按原发肿瘤部位划分的滑膜肉瘤流行病学趋势。
背景:滑膜肉瘤(SS)是一种罕见的软组织癌症:滑膜肉瘤(SS)是一种罕见的软组织癌症。现有文献包括基于监测、流行病学和最终结果(SEER)数据的 SS 研究,这些研究解释了 SS 的总体发病率、亚型和诊断年龄。因此,本研究旨在利用 SEER 数据库填补有关按肿瘤部位划分的 SS 疾病发生率和负担测量方法的知识空白:在这项横断面研究中,使用 ICD-O-3 编码 9040、9041、9042 和 9043 从 SEER 17 Registries(2000-2020 年)中选取了原发性 SS 患者。排除了患有其他癌症的患者。使用 ICD-10CM 编码将原发肿瘤部位分为 (1) 头颈部、(2) 内胸部、(3) 腹部/骨盆、(4) 上肢和 (5) 下肢。分析了五项结果:年龄调整后发病率、5 年限期发病率、发病死亡率、病死率和总生存率:从 2000 年到 2020 年,经年龄调整后的总发病率为每 10 万人 0.15 例;5 年限期发病率为每 10 万人 0.56 例;基于发病率的死亡率为每 10 万人 0.06 例。病死率和5年OS率分别为39.2%和62.9%。下肢的发病率最高,为每 10 万人 0.07 例(估计有 1166 例),患病率为每 10 万人 0.36 例(估计有 224 例),死亡率为每 10 万人 0.025 例(估计有 429 例死亡)。其他四个地点的发病率更为接近。与其他部位相比,胸腔内 SS 的病死率最高,为 71.5 %(148/207),5 年 OS 最低,为 26.0 %(95 % CI:19.6 %,32.9 %):根据发病频率的衡量标准,最常见的原发肿瘤部位是下肢,其次是上肢、腹部/骨盆、胸腔内部和头颈部。最不利的原发部位是胸腔内部。原发部位在上肢的患者总生存期最长,其次是头颈部、下肢、腹部/骨盆和胸腔内部。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Cancer Epidemiology
Cancer Epidemiology 医学-肿瘤学
CiteScore
4.50
自引率
3.80%
发文量
200
审稿时长
39 days
期刊介绍: Cancer Epidemiology is dedicated to increasing understanding about cancer causes, prevention and control. The scope of the journal embraces all aspects of cancer epidemiology including: • Descriptive epidemiology • Studies of risk factors for disease initiation, development and prognosis • Screening and early detection • Prevention and control • Methodological issues The journal publishes original research articles (full length and short reports), systematic reviews and meta-analyses, editorials, commentaries and letters to the editor commenting on previously published research.
期刊最新文献
The incidence trends of papillary thyroid carcinoma in Belarus during the post-Chernobyl epoch. Clinical profile, staging and oncological treatment of ten leading cancer types between young vs older patients from 2000 to 2019 in Brazil. Cervical cancer incidence and trends among women aged 15-29 years by county-level economic status and rurality - United States, 2007-2020. Distributions and trends in the global burden of young-onset tracheal, bronchus, and lung cancer by region, age, and sex from 1990 to 2021: An age-period-cohort analysis. Geospatial patterns by cancer stage across Australia for three common cancers.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1